(Newcastle upon Tyne, UK) Nonlinear Dynamics Ltd, a leading global
provider of bioinformatics solutions, today announced a co-marketing
agreement with Agilent Technologies Inc. to mutually promote and distribute
integrated analysis solutions. The agreement is centred on synergies
between the Agilent 2100 bioanalyzer 'lab-on-a-chip' platform and Nonlinear's
TL120 DM software. Financial terms were not disclosed.
The first stage of the agreement will see technical development to
automate the export of electropherogram data from Agilent's bioanalyzer
Expert software for analysis with Nonlinear's TotalLab TL120 DM for
the purpose of varietal identification. This collaborative solution
will enable researchers to import DNA, RNA and protein sample data from
the 2100 bioanalyzer for further relationship comparison, archiving
and data mining within TL120 DM.
Fred Strohmeier, General Manager of Agilent Technologies Liquid Phase
Analysis Business, said, "Recognising the evolutionary challenges
facing life science researchers to analyse, store and mine increasing
volumes of RNA, DNA and assay data, we are pleased to be working with
Nonlinear to enable users to discover more using the bioanalyzer platform.
Our product portfolio also incorporates the applications of mass spectrometry,
microarrays, gas and liquid chromatography. Because Nonlinear already
has various technologies available for use in these markets, there is
potential for further collaboration in the future."
Will Dracup, Group CEO of Nonlinear Dynamics, said: "Agilent's
reputation as the world's leading measurement company, coupled with
the natural synergy between the Bioanalyzer and TotalLab platform, makes
them an excellent partner. Users will benefit from the application of
independently developed, industry-tested hardware and software combined
for the first time as a powerful integrated solution."
About Nonlinear Dynamics Ltd
Established in 1989, Nonlinear Dynamics is a leading worldwide provider of bioinformatics solutions to the life science industry. The Company's innovative product portfolio comprises high-quality analysis and data mining tools for 1D and 2D electrophoresis gels and microarrays, the core technologies of genomics and proteomics. Nonlinear sells and supports its products through its UK headquarters, its USA office, and its global network of partners and OEMs.
Contact us for more information, or contact our Marketing Department directly.
Released: 11 May 2006
Current press releases | Archive press releases
